News

The ESCD executive committee would like to thank you all for your active participation in the field of Contact Dermatitis, commitment to do excellent clinical work and research and for your contributions to the ESCD. It is needed and highly appreciated.

We wish you all a Merry Christmas and are looking forward continuing working with you in 2023.

Renew your ESCD membership

We are moving into a new year, and we would like to encourage you to renew your ESCD membership today. Benefits are:

• Free online access to Contact Dermatitis
• Full voting rights and eligibility for election
• Contribute to working parties
• Up to 25% discount at ESCD Congresses
• Free online access to a searchable version of Patch Testing 5th Ed by Anton De Groot
• Free access to patient information leaflets
• Updates on allergens and baseline series

Full membership: €100 and Junior (under 35 years) & retired: €50

The ESCD works for its members but is also an important and active player in society, working for improvements for contact dermatitis patients concerning diagnosis, treatment, and prevention. The ESCD provides expert opinion to regulators and is currently working intensively to ensure the continued availability of allergens for patch testing following a change in their legal status in the EU. Please support this work by renewing your membership.

European Baseline Series (EBS) News

Since the last revision of the EBS in 2019 the ESCD taskforce has been auditing the frequency of reactions to the established allergens and recommended additions of the EBS. The work of the group has now been published in a further revision for 2023.

The article is available with free access: https://doi.org/10.1111/cod.14255 Update your baseline series now!

The group is currently considering its agenda for the next 2-3 years. If you wish to be involved please contact olivier.aerts@uza.be

Skin Allergy Meeting (SAM), Digital
24–25 March 2023

The Skin Allergy Meeting 2023 digital will be held on 24-25 March 2023 in a collaboration between EAACI and ESCD. At this event the latest developments in skin allergy and skin related disorders will be shared. We will explore new and emerging allergens in occupational allergy, cosmetic sensitizers, European baseline patch tests, cutaneous reactions to vaccines, etiology of chronic urticaria, and diagnosing and treating atopic dermatitis, among others.

If you are member of ESCD you can register at a reduced rate here

Next ESCD Congress
Dresden, 4–7 September 2024

Please save the dates of the next ESCD Congress in Dresden 2024. Preparations for the scientific program have just started and will cover the most recent research findings from basic research, clinical studies, occupational aspects, intervention and health care research.

The congress will take place at “DGUV Congress”, a new, modern congress center located next to “Dresdner Heide”, a beautiful woodland and is easily accessible from Dresden City Center and Dresden International Airport.

We are delighted to invite you to the 16. Congress of the European Society of Contact Dermatitis (ESCD) in Dresden, 04.-07 September 2024.

Dear Members, we invite you to kindly renew your membership for 2023 now. Membership dues received after 1 October 2022 will be applied to the 2023 membership year. Prices for membership remain the same for 2023.

Hand Eczema Severity Index (HECSI) is the most commonly used severity assessment tool for hand eczema. The HECSI score incorporates the extent of the eczema of both hands and six different clinical signs.

Visit hecsiscore.com for an online assessment with a photoguide and stepwise instructions.

Dear Colleagues, Dear Friends,

Amsterdam congress
The ESCD Congress in Amsterdam took place one month ago, 8–10 June 2022, after having been postponed several times due to the Covid epidemic.

Left to right: Marie-Louise Schuttelaar, Kriistina Aalto-Korte, Jeanne Duus Johansen

It was a huge success with more than 400 attendees, a multitude of scientific presentations, exchange of ideas and a very exciting social program. Thank you to all of you for contributing, and very special thanks to the organizational team led by Marie-Louise Schuttelaar.

Next Congresses

For your diaries, we’d like to remind you that the next congress will be in Dresden,
Germany, 4–7 September 2024, following which we’ll be Dublin, Ireland for 2026.

Updated Executive Committee

At the General Assembly in the Congress a renewed Executive Committee was appointed to serve for the next two years (2022–2024).

We are very excited to work with the council of national representatives and all the ESCD members to expand and further develop our Society.

New Taskforce: can you help?

A matter of priority for the ESCD is finding solutions to the difficult situation regarding
availability of patch test allergens, where a shortage is already seen in some countries due to a change in legal status of patch test allergens in the EU. An ESCD taskforce on ‘Legal matters concerning patch test materials’ has been constituted with Swen John from Osnabruck, Germany as chair. We welcome all members who are interested to join.

View the terms of reference and how to join (deadline 31 August 2022)

Updated series for 2023: invitation to comment

The European Baseline Series taskforce has developed an updated series for 2023 on
which you’re all invited to comment. Please view the document which includes how to respond. Deadline 31 August 2022

Journal IF

We are happy to announce that the new Impact Factor for the ESCD journal: Contact
Dermatitis is 6.4 for 2021, which is still high (IF 2020 was 6.6). This is very satisfying and due to a huge collective effort from all of us, authors, reviewers, editorial boards, editors, and publisher. A heartfelt thank you all.

We wish you all a very nice summer.

On behalf of the ESCD executive committee,
Jeanne Duus Johansen
President of the ESCD

To all print-on-demand subscribers, Sheridan have not received the print files for Contact Dermatitis that have come out so far this year (issues 86#1-5). As soon as the print files are received, the issues will be printed and mailed. The publisher has been made aware of the delay, and the society apologises for the inconvenience.

Dear Colleagues, Dear Friends

We are excited to finally gather in Amsterdam in June for the first ESCD Congress since 2018. All the preparations to make the ESCD Congress 2022 a congress to remember have been made and we proudly present our scientific program. Haven’t registered yet? No problem, it’s not too late! Join your colleagues during this international congress. Book at escd2022.com We hope to see you in less than three weeks!

COVID-regulations
Our conference venue Beurs van Berlage follows all the guidelines and regulations of the RIVM (Dutch health care institute) and the protocol of the event industry. We are happy to inform you that there are no COVID restrictions apply to our conference. The ESCD Congress 2022 will be a safe environment for you and your colleagues.

We look forward to welcoming you in Amsterdam in June!

escd2022.com

On behalf of the local organisers

Kristiina Aalto-Korte
President, ESCD

The Executive Committee is pleased to announce that, from now on, members of the ESCD have online access to the full contents of Anton de Groot’s well-known book Patch Testing (5th edition, 2022).

The book contains 5200 chemicals with patch test concentrations and vehicles, 2350 synonyms, CAS numbers for all chemicals, patch test concentrations and vehicles for products and for groups of chemically or functionally related groups of chemicals, reports of photosensitivity, contact urticaria, and patch test sensitization, commercial availability of allergens and much more.

Searches can be performed for chemical names, partial names, CAS numbers or general text.

The Executive Committee is very grateful to Anton for his generous donation of the book.

ESCD Executive Committee

Anton de Groot’s new book Monographs in Contact Allergy, Volume 4 – Systemic drugs has been published recently. This book provides monographs of 507 systemic drugs which have caused delayed-type cutaneous drug hypersensitivity reactions (e.g., maculopapular eruption, acute generalized exanthematous pustulosis [AGEP], symmetrical drug-related intertriginous and flexural exanthema [SDRIFE], fixed drug eruption, drug reaction with eosinophilia and systemic symptoms [DRESS], and photosensitivity) and/or occupational allergic contact dermatitis, in which delayed-type hypersensitivity was shown by positive patch tests.

View the table of contents with the preface and two sample chapters ‘Clindamycin’ and ‘Diltiazem’.

More information

Dear friends,

In 2020, the congress in Amsterdam had to be postponed twice due to the pandemic, but now, thanks to the vaccines, the world is finally opening!

The new date for the Amsterdam congress is approaching, and quite many colleagues have already registered.

On the contrary to the huge congresses, the ESCD congresses have always offered an easy possibility for true communication between scientists. I think it is of utmost importance for the whole scientific community that the tradition of face-to-face gatherings continues. Since London 1996, I have always come back home from the ESCD congresses with lots of new ideas and knowledge, many acquired in
the coffee and lunch breaks and social events.

With this letter I want to encourage you to come on site in Amsterdam, also you who have poster presentations.

I wish you all welcome in Amsterdam in the ESCD congress on 8−10 June!

Book today at https://escd2022.com/

On behalf of the Executive Committee

Kristiina Aalto-Korte
President ESCD

Are you a print subscriber of the journal and wonder when a new issue is released? Wiley have a notification system, watch the video walkthrough below to get reminders sent to your inbox. Watch now.